{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:10:18Z","timestamp":1794708618717,"version":"4.9.1"},"reference-count":165,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>A family history of melanoma greatly increases the risk of developing cutaneous melanoma, a highly aggressive skin cancer whose incidence has been steadily increasing worldwide. Familial melanomas account for about 10% of all malignant melanomas and display an inheritance pattern consistent with the presence of pathogenic germline mutations, among which those involving CDKN2A are the best characterized. In recent years, a growing number of genes, such as MC1R, MITF, CDK4, POT1, TERT, ACD, TERF2IP, and BAP1, have been implicated in familial melanoma. The fact that individuals harboring these germline mutations along with their close blood relatives have a higher risk of developing multiple primary melanomas as well as other internal organ malignancies, especially pancreatic cancer, makes cascade genetic testing and surveillance of these families of the utmost importance. Unfortunately, due to a polygenic inheritance mechanism involving multiple low-risk alleles, genetic modifiers, and environmental factors, it is still very difficult to predict the presence of these mutations. It is, however, known that germline mutation carriers can sometimes develop specific clinical traits, such as high atypical nevus counts and specific dermoscopic features, which could theoretically help clinicians predict the presence of these mutations in prone families. In this review, we provide a comprehensive overview of the high- and intermediate-penetrance genes primarily linked to familial melanoma, highlighting their most frequently associated non-cutaneous malignancies and clinical\/dermoscopic phenotypes.<\/jats:p>","DOI":"10.3390\/jcm10163760","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T21:59:00Z","timestamp":1629755940000},"page":"3760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0128-7379","authenticated-orcid":false,"given":"Lamberto","family":"Zocchi","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Dermatology Clinic, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lontano","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Dermatology Clinic, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Merli","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Dermatology Clinic, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-2861","authenticated-orcid":false,"given":"Emi","family":"Dika","sequence":"additional","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-8707","authenticated-orcid":false,"given":"Eduardo","family":"Nagore","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Instituto Valenciano de Oncolog\u00eda, 46009 Val\u00e8ncia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Dermatology Clinic, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Puig","sequence":"additional","affiliation":[{"name":"Melanoma Unit, Dermatology Department, Hospital Cl\u00ednic de Barcelona, IDIBAPS, Universitat de Barcelona, 08001 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Dermatology Clinic, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1200\/JCO.2005.11.999","article-title":"Population-based analysis of prognostic factors and survival in familial melanoma","volume":"23","author":"Florell","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: From mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-4632.2010.04381.x","article-title":"Defining the patient at high risk for melanoma","volume":"49","author":"Psaty","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","article-title":"Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","first-page":"210","article-title":"Update in genetic susceptibility in melanoma","volume":"3","author":"Potrony","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"677.e1","DOI":"10.1016\/j.jaad.2009.03.016","article-title":"Selection criteria for genetic assessment of patients with familial melanoma","volume":"61","author":"Leachman","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2006","journal-title":"J. Med. Genet."},{"key":"ref_8","first-page":"559","article-title":"Natural and orthogonal model for estimating gene\u2013gene interactions applied to cutaneous melanoma","volume":"133","author":"Xiao","year":"2014","journal-title":"Qual. Life Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Maccioni, L., Rachakonda, P.S., Bermejo, J.L., Planelles, D., Requena, C., Hemminki, K., Nagore, E., and Kumar, R. (2013). Variants at the 9p21 locus and melanoma risk. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-325"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2009.068122","article-title":"Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer","volume":"46","author":"Hitchins","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","article-title":"Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia","volume":"129","author":"Raval","year":"2007","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13148-020-00831-7","article-title":"Genome-wide analysis of constitutional DNA methylation in familial melanoma","volume":"12","author":"Salgado","year":"2020","journal-title":"Clin. Epigenet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.seminoncol.2016.08.003","article-title":"Genetic predisposition to melanoma","volume":"43","author":"Hawkes","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pcmr.12333","article-title":"Genetics of familial melanoma: 20 years afterCDKN2A","volume":"28","author":"Aoude","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamadermatol.2015.4356","article-title":"Prevalence of MITF p.E318K in Patients with Melanoma Independent of the Presence of CDKN2A Causative Mutations","volume":"152","author":"Potrony","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bjd.14897","article-title":"Genetic susceptibility to cutaneous melanoma in southern Switzerland: Role of CDKN2A, MC1R and MITF","volume":"175","author":"Mangas","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/gim.2015.160","article-title":"Characterization of individuals at high risk of developing melanoma in Latin America: Bases for genetic counseling in melanoma","volume":"18","author":"Puig","year":"2016","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaad.2015.09.053","article-title":"Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup","volume":"74","author":"Bruno","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2004.12.033","article-title":"Cutaneous melanoma susceptibility and progression genes","volume":"230","author":"Hayward","year":"2005","journal-title":"Cancer Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/92.12.1006","article-title":"Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations","volume":"92","author":"Goldstein","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2010.086538","article-title":"Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK","volume":"48","author":"Cust","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1897-4287-12-20","article-title":"Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom","volume":"12","author":"Harland","year":"2014","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.137.11.1493","article-title":"Genetic epidemiology of cutaneous melanoma: A global perspective","volume":"137","author":"Goldstein","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL","volume":"66","author":"Bishop","year":"2006","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","article-title":"High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families","volume":"51","author":"Helgadottir","year":"2014","journal-title":"J. Med. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ejhg.2010.198","article-title":"Prevalence of CDKN2A mutations in pancreatic cancer patients: Implications for genetic counseling","volume":"19","author":"McWilliams","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.22712","article-title":"Cutaneous phenotype andMC1R variants as modifying factors for the development of melanoma inCDKN2A G101W mutation carriers from 4 countries","volume":"121","author":"Goldstein","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/gim.2017.216","article-title":"Phenocopies in melanoma-prone families with germ-line CDKN2A mutations","volume":"20","author":"Helgadottir","year":"2017","journal-title":"Genet. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2014.06.036","article-title":"Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling","volume":"71","author":"Potrony","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","article-title":"Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)","volume":"87","author":"Vasen","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/CMR.0000000000000442","article-title":"CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer","volume":"28","author":"Banuls","year":"2018","journal-title":"Melanoma Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2019.01.027","article-title":"Large-scale meta-analysis of mutations identified in panels of breast\/ovarian cancer-related genes\u2014Providing evidence of cancer predisposition genes","volume":"153","author":"Suszynska","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1038\/ncomms8553","article-title":"Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng.585","article-title":"Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk","volume":"42","author":"Sherborne","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jnci\/djs221","article-title":"Risk of Non-Melanoma Cancers in First-Degree Relatives of CDKN2A Mutation Carriers","volume":"104","author":"Mukherjee","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/NP301022","article-title":"Familial melanoma-astrocytoma syndrome: Synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A\/B deletion and a significant family history","volume":"36","author":"Chan","year":"2017","journal-title":"Clin. Neuropathol."},{"key":"ref_38","first-page":"889","article-title":"Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families","volume":"9","author":"Goldstein","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.2897","article-title":"Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility","volume":"46","author":"Mahajan","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.2005.08.034","article-title":"Role of the CDKN2A Locus in Patients with Multiple Primary Melanomas","volume":"23","author":"Puig","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jid.2016.01.009","article-title":"Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families","volume":"136","author":"Taylor","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaad.2010.06.044","article-title":"Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A","volume":"65","author":"Krijnen","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/pcmr.12820","article-title":"Body site-specific genetic effects influence naevus count distribution in women","volume":"33","author":"Visconti","year":"2019","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.0022-202X.2004.23312.x","article-title":"Longitudinal assessment of the nevus phenotype in a melanoma kindred","volume":"123","author":"Florell","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/CMR.0b013e3283341339","article-title":"Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype","volume":"20","author":"Nielsen","year":"2010","journal-title":"Melanoma Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2340\/00015555-1457","article-title":"Melanocortin 1 Receptor (MC1R) Variants in High Melanoma Risk Patients are Associated with Specific Dermoscopic ABCD Features","volume":"92","author":"Quint","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2133.2008.08826.x","article-title":"Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers","volume":"160","author":"Puig","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/exd.12168","article-title":"CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients","volume":"22","author":"Bassoli","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5826\/dpc.0901a03","article-title":"Familial melanoma: Diagnostic and management implications","volume":"9","author":"Rossi","year":"2019","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","article-title":"Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals","volume":"142","author":"Canto","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10689-017-0057-z","article-title":"Development of a high risk pancreatic screening clinic using 3.0 T MRI","volume":"17","author":"Barnes","year":"2017","journal-title":"Fam. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0749.2005.00278.x","article-title":"Melanocortin-1 receptor structure and functional regulation","volume":"18","year":"2005","journal-title":"Pigment Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.2015.231","article-title":"MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project","volume":"113","author":"Tagliabue","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte\u2013stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/hmg\/6.11.1891","article-title":"Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair","volume":"6","author":"Box","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jdermsci.2016.09.004","article-title":"Sex and MC1R variants in human pigmentation: Differences in tanning ability and sensitivity to sunlight between sexes","volume":"84","author":"Hernando","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2018.1252","article-title":"Contributions by MC1R Variants to Melanoma Risk in Males and Females","volume":"154","author":"Wendt","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/jid.2008.67","article-title":"MC1R Variants Increase Risk of Melanomas Harboring BRAF Mutations","volume":"128","author":"Fargnoli","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.1127515","article-title":"MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma","volume":"313","author":"Landi","year":"2006","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/jid.2012.385","article-title":"NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: Findings from Spanish and Austrian populations","volume":"133","author":"Hacker","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.jid.2017.07.832","article-title":"Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma","volume":"137","author":"Thomas","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ejca.2010.01.027","article-title":"MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis","volume":"46","author":"Fargnoli","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1038\/ncomms12064","article-title":"Germline MC1R status influences somatic mutation burden in melanoma","volume":"7","author":"Espinoza","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12326950","article-title":"Proopiomelanocortin, Its Derived Peptides, and the Skin","volume":"106","author":"Wintzen","year":"1996","journal-title":"J. Investig. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1749-6632.1999.tb08682.x","article-title":"Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression","volume":"885","author":"Kalden","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.23396","article-title":"MC1R variants, melanoma and red hair color phenotype: A meta-analysis","volume":"122","author":"Raimondi","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 Receptor Polymorphisms and Risk of Melanoma: Is the Association Explained Solely by Pigmentation Phenotype?","volume":"66","author":"Palmer","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","article-title":"Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma Which is Largely Independent of Skin Type and Hair Color","volume":"117","author":"Kennedy","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1136\/jmg.2003.011536","article-title":"Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure","volume":"41","author":"Matichard","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/jnci\/djq363","article-title":"Association of MC1R Variants and Host Phenotypes with Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study","volume":"102","author":"Demenais","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1055-9965.EPI-04-0777","article-title":"Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees","volume":"14","author":"Chaudru","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/323411","article-title":"Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma","volume":"69","author":"Sandkuijl","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/hmg\/10.16.1701","article-title":"The melanocortin-1-receptor gene is the major freckle gene","volume":"10","author":"Bastiaens","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/hmg\/ddh043","article-title":"Interactive effects of MC1R and OCA2 on melanoma risk phenotypes","volume":"13","author":"Duffy","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_76","first-page":"1042","article-title":"Children with red hair have more freckles but fewer melanocytic nevi: Results from a cohort study of 280 three-year-olds","volume":"141","author":"Dodd","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjd.12418","article-title":"Distribution ofMC1Rvariants among melanoma subtypes: P.R163Q is associated with lentigo maligna melanoma in a Mediterranean population","volume":"169","author":"Carrera","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_78","first-page":"516","article-title":"Interaction between the melanocortin-1 receptor and P genes contributes to inter-individual variation in skin pigmentation phenotypes in a Tibetan population","volume":"108","author":"Akey","year":"2001","journal-title":"Qual. Life Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cncr.24994","article-title":"Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?","volume":"116","author":"Kanetsky","year":"2010","journal-title":"Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/CMR.0000000000000323","article-title":"Characterization of melanoma susceptibility genes in high-risk patients from Central Italy","volume":"27","author":"Pellegrini","year":"2017","journal-title":"Melanoma Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1755-148X.2008.00526.x","article-title":"MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters","volume":"22","author":"Tuominen","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/pcmr.12646","article-title":"Melanocortin 1 receptor (MC1R ) polymorphisms\u2019 influence on size and dermoscopic features of nevi","volume":"31","author":"Vallone","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/00015555-1021","article-title":"Early Stages of Melanoma on the Limbs of High-risk Patients: Clinical, Dermoscopic, Reflectance Confocal Microscopy and Histopathological Characterization for Improved Recognition","volume":"91","author":"Carrera","year":"2011","journal-title":"Acta Derm. Venereol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1158\/1055-9965.EPI-14-0633","article-title":"Interactions between Ultraviolet Light and MC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes","volume":"23","author":"Asdigian","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/jid.2012.95","article-title":"Germline Melanocortin-1-Receptor Genotype Is Associated with Severity of Cutaneous Phenotype in Congenital Melanocytic Nevi: A Role for MC1R in Human Fetal Development","volume":"132","author":"Kinsler","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/pcmr.12883","article-title":"Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi","volume":"33","author":"Potrony","year":"2020","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/jdv.12411","article-title":"Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype","volume":"28","author":"Fargnoli","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jdv.16679","article-title":"Dermoscopy comparative approach for early diagnosis in familial melanoma: Influence of MC1R genotype","volume":"35","author":"Longo","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-148X.2009.00653.x","article-title":"Fifteen-year quest for microphthalmia-associated transcription factor target genes","volume":"23","author":"Cheli","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","article-title":"A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma","volume":"480","author":"Yokoyama","year":"2011","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12047","article-title":"Prevalence of the E318K MITF germline mutation in Italian melanoma patients: Associations with histological subtypes and family cancer history","volume":"26","author":"Ghiorzo","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1210\/jc.2016-2103","article-title":"The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma","volume":"101","author":"Kiando","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jid.2013.272","article-title":"Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients","volume":"134","author":"Sturm","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12967-020-02253-8","article-title":"Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients","volume":"18","author":"Ciccarese","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/pcmr.12215","article-title":"MITF E318K\u2019s effect on melanoma risk independent of, but modified by, other risk factors","volume":"27","author":"Berwick","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/CMR.0000000000000427","article-title":"Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation","volume":"28","author":"Bassoli","year":"2018","journal-title":"Melanoma Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jmedgenet-2012-101455","article-title":"Melanoma prone families with CDK4 germline mutation: Phenotypic profile and associations with MC1R variants","volume":"50","author":"Puntervoll","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_99","first-page":"dju408","article-title":"Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma","volume":"107","author":"Aoude","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/carcin\/bgp268","article-title":"Telomeres and telomerase in cancer","volume":"31","author":"Artandi","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2947","article-title":"POT1 loss-of-function variants predispose to familial melanoma","volume":"46","author":"Espinoza","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.2941","article-title":"Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma","volume":"46","author":"Shi","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaad.2020.03.100","article-title":"Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain","volume":"83","author":"Sargen","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.2843","article-title":"A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia","volume":"46","author":"Speedy","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1038\/ncomms9383","article-title":"A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li\u2013Fraumeni-like families","volume":"6","author":"Calvete","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11883","DOI":"10.1038\/ncomms11883","article-title":"Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer","volume":"7","author":"Chubb","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10689-017-9984-y","article-title":"A new POT1 germline mutation\u2014Expanding the spectrum of POT1-associated cancers","volume":"16","author":"Wilson","year":"2017","journal-title":"Fam. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnci\/dju384","article-title":"Germline Mutations in Shelterin Complex Genes Are Associated with Familial Glioma","volume":"107","author":"Bainbridge","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1541-7786.MCR-14-0305","article-title":"Telomere-regulating genes and the telomere interactome in familial cancers","volume":"13","author":"Hayward","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/ctg.2014.3","article-title":"The Association of Telomere Length with Colorectal Cancer Differs by the Age of Cancer Onset","volume":"5","author":"Boardman","year":"2014","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10689-015-9841-9","article-title":"Germline TERT promoter mutations are rare in familial melanoma","volume":"15","author":"Harland","year":"2016","journal-title":"Fam. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajh.23842","article-title":"Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms","volume":"89","author":"Harutyunyan","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11899-017-0414-x","article-title":"Familial MPN Predisposition","volume":"12","author":"Tashi","year":"2017","journal-title":"Curr. Hematol. Malign. Rep."},{"key":"ref_115","first-page":"197","article-title":"Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: Findings from the Los Angeles\u2013Shanghai bladder case\u2013control study","volume":"32","author":"Jiang","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.2012.329","article-title":"The TERT variant rs2736100 is associated with colorectal cancer risk","volume":"107","author":"Kinnersley","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.3101","article-title":"Genome-wide analysis of noncoding regulatory mutations in cancer","volume":"46","author":"Weinhold","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ng.882","article-title":"Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study","volume":"43","author":"Giles","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jmedgenet-2011-100001","article-title":"Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour","volume":"48","author":"Kratz","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ng.985","article-title":"A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer","volume":"43","author":"Haiman","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/ijc.29279","article-title":"TERT promoter mutations in clear cell renal cell carcinoma","volume":"136","author":"Hosen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Calado, R.T., Regal, J.A., Kleiner, D.E., Schrump, D.S., Peterson, N.R., Pons, V., Chanock, S.J., Lansdorp, P.M., and Young, N.S. (2009). A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007926"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/hep.24217","article-title":"Telomerase gene mutations are associated with cirrhosis formation","volume":"53","author":"Hartmann","year":"2011","journal-title":"Hepatology"},{"key":"ref_124","first-page":"579","article-title":"Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls","volume":"132","author":"Brenner","year":"2013","journal-title":"Qual. Life Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/ng.254","article-title":"Lung cancer susceptibility locus at 5p15","volume":"40","author":"McKay","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/ng.273","article-title":"Common 5p15.33 and 6p21.33 variants influence lung cancer risk","volume":"40","author":"Wang","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Burke, L.S., Hyland, P.L., Pfeiffer, R.M., Prescott, J., Wheeler, W., Mirabello, L., Savage, S.A., Burdette, L., Yeager, M., and Chanock, S. (2013). Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071121"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bjd.13467","article-title":"Genetic factors associated with naevus count and dermoscopic patterns: Preliminary results from the Study of Nevi in Children (SONIC)","volume":"172","author":"Orlow","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ncb2081","article-title":"Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites","volume":"12","author":"Martinez","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncb2080","article-title":"Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression","volume":"12","author":"Teo","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-18-0099","article-title":"A Rare Variant P507L in TPP1 Interrupts TPP1\u2013TIN2 Interaction, Influences Telomere Length, and Confers Colorectal Cancer Risk in Chinese Population","volume":"27","author":"Li","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2014-08-596445","article-title":"Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP","volume":"124","author":"Guo","year":"2014","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2015.08.037","article-title":"Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling","volume":"74","author":"Soura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Njauw, C.-N.J., Kim, I., Piris, A., Gabree, M., Taylor, M., Lane, A.M., DeAngelis, M.M., Gragoudas, E., Duncan, L.M., and Tsao, H. (2012). Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035295"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/pcmr.12046","article-title":"Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases","volume":"26","author":"Aoude","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Liao","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 Mutations Predispose to Renal Cell Carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pathol.2016.03.005","article-title":"Loss of expression of BAP1 is very rare in non-small cell lung carcinoma","volume":"48","author":"Andrici","year":"2016","journal-title":"Pathology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Pilarski","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A crypticBAP1splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e2491","DOI":"10.1097\/MD.0000000000002491","article-title":"Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma","volume":"95","author":"Andrici","year":"2016","journal-title":"Medicine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cancergen.2015.12.007","article-title":"A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer","volume":"209","author":"McDonnell","year":"2016","journal-title":"Cancer Genet."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germlineBAP1mutation and extension of theBAP1tumor predisposition spectrum to include basal cell carcinoma","volume":"88","author":"Wadt","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.pathol.2017.03.005","article-title":"Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma","volume":"49","author":"Rawson","year":"2017","journal-title":"Pathology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: Malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"677","DOI":"10.6004\/jnccn.2018.7012","article-title":"Integrated Histogenetic Analysis Reveals BAP1 -Mutated Epithelioid Mesothelioma in a Patient with Cancer of Unknown Primary","volume":"16","author":"Bochtler","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations","volume":"8","author":"Zauderer","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical Characteristics of Uveal Melanoma in Patients with GermlineBAP1Mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00401-015-1423-2","article-title":"Primary leptomeningeal melanoma is part of the BAP1-related cancer syndrome","volume":"129","author":"Cabaret","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal Melanoma: Trends in Incidence, Treatment, and Survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/13816810.2015.1010734","article-title":"Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients","volume":"36","author":"Cebulla","year":"2013","journal-title":"Ophthalmic Genet."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Aoude, L.G., Wadt, K., Bojesen, A., Cruger, R., Borg, A., Trent, J.M., Brown, K.M., Gerdes, A.-M., Jonsson, G., and Hayward, N. (2013). A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072144"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/gcc.22035","article-title":"Hereditary uveal melanoma: A report of a germline mutation in BAP","volume":"52","author":"Helgadottir","year":"2013","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamadermatol.2015.1701","article-title":"Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient with a Novel Germline BAP1 Mutation","volume":"151","author":"Gerami","year":"2015","journal-title":"JAMA Dermatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an Improved Definition of the Tumor Spectrum Associated with BAP1 Germline Mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaad.2018.09.014","article-title":"Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society","volume":"80","author":"Marchetti","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/ijd.12386","article-title":"Ocular melanoma and the BAP1 hereditary cancer syndrome: Implications for the dermatologist","volume":"53","author":"Martorano","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","article-title":"Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature","volume":"153","author":"Haugh","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/bjd.16740","article-title":"Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus\/tumour in two familial cases of BAP1 syndrome","volume":"179","author":"Moawad","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_163","first-page":"365","article-title":"Biologically distinct subsets of nevi","volume":"151","author":"Rogers","year":"2016","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Iris Zalaudek, G.A., and Giacomel, J. (2015). Nevi in patients with BAP1 germ line mutation, red-hair polymorphism, and albinism. Dermatoscopy of Non-Pigmented Skin Tumors, CRC Press.","DOI":"10.1201\/b18754"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review ofBAP1tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin. Genet."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/16\/3760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:50:03Z","timestamp":1760165403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/16\/3760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":165,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["jcm10163760"],"URL":"https:\/\/doi.org\/10.3390\/jcm10163760","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}